Omega Therapeutics, Inc. (OMGA) Financials
Stock symbol OMGA is outdated, potentially delisted? Maybe it is available on other exchange?
OMGA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 168.2 million | 142.0 million |
| March 31, 2024 | 183.7 million | 142.3 million |
| Dec. 31, 2023 | 204.4 million | 146.4 million |
| Sept. 30, 2023 | 217.8 million | 141.8 million |
OMGA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -13.1 million | 1.2 million |
| March 31, 2024 | -12.3 million | 3.4 million |
| Dec. 31, 2023 | -18.2 million | 2.1 million |
| Sept. 30, 2023 | -23.8 million | 2.3 million |
OMGA Net Income
No data available :(
OMGA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 45.9 million | 111.1 million | 110.0 million |
| March 31, 2024 | 60.0 million | 13.9 million | 97.7 million |
| Dec. 31, 2023 | 73.4 million | 14.9 million | 98.2 million |
| Sept. 30, 2023 | 89.3 million | 114.6 million | 111.3 million |
OMGA Shares Outstanding
OMGA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 396000 | 12.9 million | 5.8 million | 687000 |
| March 31, 2024 | 535000 | 15.4 million | 5.6 million | -1.8 million |
| Dec. 31, 2023 | 1.1 million | 15.5 million | 4.4 million | -1.8 million |
| Sept. 30, 2023 | 724000 | 16.5 million | 7.9 million | - |
OMGA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 2.1 million | 9.3 million |
| March 31, 2024 | 2.4 million | 1.8 million |
| Dec. 31, 2023 | 989000 | 1.8 million |
| Sept. 30, 2023 | 831000 | 1.9 million |
OMGA
Price: $0.14
52 week price:
Earnings Per Share: -1.32 USD
P/E Ratio: -0.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.4 million